Sequential Neo-adjuvant Chemotherapy Followed by Capecitabine Vs. Conventional Adjuvant Chemotherapy in Breast Cancer
Status:
Recruiting
Trial end date:
2025-02-01
Target enrollment:
Participant gender:
Summary
This study evaluates whether sequential neo-adjuvant chemotherapy plus surgery followed by
Capecitabine could achieve additional benefits over traditional postoperative chemotherapy.
In the study group, patients that do not achieve pathological complete response(pCR) will
receive sequential neo-adjuvant chemotherapy followed by Capecitabine. In the control group,
patients will be treated with postoperative adjuvant chemotherapy.
Phase:
Phase 3
Details
Lead Sponsor:
First Hospital of Jilin University The First Hospital of Jilin University
Collaborators:
Baotou Cancer Hospital First Affiliated Hospital Xi'an Jiaotong University First Hospital of China Medical University Qingdao University The Second Affiliated Hospital of Harbin Medical University